Drug metabolism & elimination -4 Flashcards
Elimination
any process that inactivates or leads to the removal of an active drug from the body. Elimination is typically more efficient for hydrophilic (water soluble or polar) drugs.
Hepatic metabolism, renal excretion, biliary & fecal excretion, lung metabolism, plasma & extracellular enzymes, spontaneous degradation, alveolar expiration.
Total body clearance (TBC)
a theoretical measure of the plasma volume that is cleared of drug during any given period of time- expressed as a volume of plasma that a cleared completely of drug. Defined as the product of the apparent volume of distribution and the elimination rate constant (Ke). TBC= Vd X Ke.
Equivalent to the sum of individual organ clearance rates for first-order elimination processes. TBC= C renal + C hepatic + …
Renal clearance
involves 3 distinct processes for many drugs: glomerular filtration, tubular secretion, tubular reabsorption.
In the calculation of renal drug clearance, TR is subtracted, since this process removes drug from provisional urine.
CL renal= GF + TS - TR.
Many drugs are eliminated predominantly or entirely by renal clearance. Clearance can be altered markedly by certain diseases or disorders.
Glomerular filtration
of free (unbound) drug is determined by renal perfusion or glomerular filtration rate (GFR). Proportional to cardiac output, not affected by net drug charge, reduced for protein bound drugs.
Tubular secretion
is an active carrier-mediated process primarily in the proximal tubules. Distinct carriers for acidic and basic drugs. Opportunity for drug interactions.
Tubular reabsorption
is a passive diffusion-driven process that depends primarily on net drug charge. Neutral form is reabsorbed preferentially (charged form less permeant). Strongly affected be changes in urinary pH (opportunity for intervention).
Hypoalbuminemia
age, burns, hepatic disease, nutritional.
Decreases drug protein binding leads to increases filtration= increased clearance.
Cardiac insufficiency
shock, cardiomyopathy, ect.
Decreased GFR leads to decreased clearance.
Acid base imbalances
respiratory or metabolic origin.
Altered pH leads to a change in drug charge leading to change in tubular reabsorption.
Hepatic drug clearance
involves a wide spectrum of enzyme catalyzed biotransformation reactions. Liver is well suited for drug metabolism- high blood flow, gaps in endothelial cells, unusual cytoarchitecture. Effects usefulness of a oral administration.
First pass effect- hepatic drug clearance
is the extent to which an orally administered drug is metabolized during its first pass through the portal circulation. Can range from 0-100%. Saturable in some cases.
Drugs with a high first pass effect should be used with caution in animals with hepatic disease.
Drug metabolism
can occur in any tissue, but most often is catalyzed in liver. Renders drugs more polar (increased water solubility). Broadly sub-divided into two categories. Phase 1 reactions and phase 2 reactions.
Drugs that are metabolized by the same family of hepatic CYP isoymes can compete with one another. Drugs can act as inhibitors or as inducers of CYP izozymes.
Phase 1 reations
catalyzed by cytochrome P enzymes. a) four families (1-4) b) six sub families (A-F) c) up to 20 isoenzymes (1-20) produces chemical modifications of the parents drug. oxidation, reduction, hydrolysis, etc.
Phase 2 reactions
coupling reactions of drug with an endogenous substance.
Glucuronidation, sulfation, acetylation, etc.
Species/strain differences
cats- poor at glucuronide conjugation (morphine).
dogs- poor acetylation of sulfonamides.
pigs- xylazine.
rabbits- atropine (belladonna alkaloids)